Does IBALIZUMAB-UIYK Cause Product dose omission? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Product dose omission have been filed in association with IBALIZUMAB-UIYK. This represents 2.6% of all adverse event reports for IBALIZUMAB-UIYK.
11
Reports of Product dose omission with IBALIZUMAB-UIYK
2.6%
of all IBALIZUMAB-UIYK reports
2
Deaths
6
Hospitalizations
How Dangerous Is Product dose omission From IBALIZUMAB-UIYK?
Of the 11 reports, 2 (18.2%) resulted in death, 6 (54.5%) required hospitalization.
Is Product dose omission Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IBALIZUMAB-UIYK. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does IBALIZUMAB-UIYK Cause?
Rash (40)
Product dose omission issue (37)
Viral load increased (37)
Drug ineffective (31)
Hospitalisation (30)
Diarrhoea (28)
Fatigue (28)
Pruritus (24)
Nausea (22)
Death (21)
What Other Drugs Cause Product dose omission?
APREMILAST (4,567)
DUPILUMAB (2,729)
ALBUTEROL (1,742)
USTEKINUMAB (1,653)
INSULIN GLARGINE (1,500)
ETANERCEPT (1,400)
LENALIDOMIDE (1,400)
RUXOLITINIB (1,376)
ALIROCUMAB (1,354)
DIMETHYL (1,248)
Which IBALIZUMAB-UIYK Alternatives Have Lower Product dose omission Risk?
IBALIZUMAB-UIYK vs IBANDRONATE
IBALIZUMAB-UIYK vs IBANDRONIC ACID
IBALIZUMAB-UIYK vs IBERDOMIDE
IBALIZUMAB-UIYK vs IBREXAFUNGERP
IBALIZUMAB-UIYK vs IBRITUMOMAB TIUXETAN